Login / Signup

The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Lexun WangLei XiangShenghua PiaoXiao GongWanxing ZhouWeixun FengHuilin LiLeyu LiAisheng WeiQing ZhuXianglu RongJiao Guo
Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
This trial was registered in the Chinese Clinical Trial Registry on April 07, 2019 (No. ChiCTR1900022345).
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • phase ii study
  • open label
  • type diabetes
  • randomized controlled trial
  • wound healing
  • squamous cell carcinoma